Back to top

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

Valic Co I Health Sciences Fd: (MF: VCHSX)

(MF) As of Feb 26, 2015 06:06 PM ET

 Add to portfolio

$25.16 USD

+0.08 (0.32%)

Zacks MF Rank : 2 - Buy [?]   2      

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

General Information as of Jan 31, 2015

% Yield 0.00
% SEC Yield NA
% YTD Return (as of Jan 31, 2015) 4.31
Objective Sector - Health
Peer HL MG

Zacks Premium Research for VCHSX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Buy 2
MF Research Report

( = Change in last 30 days)

Zacks Mutual Fund #1 Ranked Funds

View the Zacks Mutual Fund Rank Guide

Portfolio Statistics

%Unrealized Gain YTD 35.61
Net Assets (Mil $) 1/31/2015 580.16
%Turnover 1/31/2015 59.00

Allocation

% of Portfolio
Large Growth 58.30
Large Value 0.00
Small Growth 15.70
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 0.00
High Yield Bond 0.00

Sector / Country Weightings

As of 1/31/2015 % of Portfolio
Health 46.22
Services 14.33
Other 9.72
Finance 9.23
Retail Trade 8.41
Industrial Cyclical 7.02
Technology 4.35
Non-Durable 0.72

Portfolio Holdings

Top Equity Holdings
(As of 8/31/2014)
% of Portfolio Value (Mil$)
GILEAD SCIENCES INC 5.64 37.06
ALEXION PHARMACEUTICALS I 4.71 30.95
BIOGEN IDEC INC 3.39 22.26
MCKESSON CORP 3.32 21.82
AETNA INC 3.18 20.90
PUMA BIOTECHNOLOGY INC 2.98 19.54
ACTAVIS PLC 2.96 19.45
INTERMUNE INC 2.84 18.68
UNITEDHEALTH GROUP INC 2.83 18.58

Stock Holding % of Net Assets

As Of 8/31/2014
Total Issues 144
Avg. P/E 26.69
Avg. P/Book 4.84
Avg. EPS Growth 12.82
Avg. Market Value (Mil $) 39,403

Risk

3 Year 5 Year 10 Year
Beta 0.89 0.90 NA
Alpha 18.12 13.14 NA
R Squared 0.39 0.59 NA
Std. Dev. 13.16 15.20 NA
Sharpe 2.76 1.94 NA